You are here: Industry Insights > Chinese

News List

Boehringer Ingelheim increases focus on Chinese rural areas biospectrumasia
April 23, 2019
German pharmaceutical company Boehringer Ingelheim is increasingly focusing on the rural areas of China, which generated almost 30 per cent of its net sales, taking the total net sales in China in 2018 to 658 million euros.
U.S. government forces Chinese divestiture in health data startup PatientsLikeMe: report fiercepharma
April 08, 2019
Real-world data gatherer PatientsLikeMe has to shop for a new buyer—and quickly—after the Trump administration ordered a Chinese company to divest its majority stake, according to a report from CNBC.
New US trade policy may limit foreign investment into biotechs pharmafile
November 20, 2018
The US Trump Administration have issued new rules, which will put foreign investment into companies involved in the development and testing of critical technologies
Parents demonstrate in response to Chinese vaccine scandal pharmafile
August 02, 2018
Concerned parents have begun demonstrating in Beijing in response to the Changsheng Biotechnology vaccine scandal.
Top Chinese rabies vaccine maker ordered to stop production over forged data fiercevaccines
July 23, 2018
China’s drug regulator just pulled a manufacturing permit for the country’s second-largest maker of rabies vaccines over data falsification, marking the latest episode in China’s drug safety scandal.
Athenex rakes in $100M, sets up Chinese TCR-focused JV fiercebiotech
July 09, 2018
Just over a year since its IPO, Athenex is broadening its scope—the biotech is picking up a $100 million investment from Perceptive Advisors, licensing a modified cancer-fighting enzyme and launching a new Chinese joint venture built around T-cell recepto
UK and Chinese scientists partner on new medicines for epidemics pharmaceutical-technology
June 13, 2018
Researchers at the University of Birmingham, UK, are collaborating with scientists from China’s Guangzhou Institutes of Biomedicine and Health (GIBH) to develop new medicines for treating global epidemics.
With global supplies running short, stepped-up Chinese demand paralyzes Gardasil market in Hong Kong, S.A.R., China fiercepharma
May 29, 2018
Before Merck & Co.'s Gardasil 9 won conditional approval on the mainland just last month...
Chinese chemical firms forced to stop production newsnow
May 14, 2018
Environmental protection authorities have ordered several Chinese chemical producers listed on the Shanghai Stock Exchange to suspend operations at their plants in Jiangsu province.
Shanghai's SARI Pays $359M for Italian Cancer Biopharma NMS biospace
January 02, 2018
Nerviano (Milano), December 27, 2017 - SARI, a Chinese market-leader biotech investment company, today announced it has entered into an agreement to acquire the 90% interests in Group NMS

Previous page 1 2 3 Next page